A Novel Recombinant Fusion Protein Exhibited Inhibitory Activities on Platelet Aggregation and Thrombin

被引:0
|
作者
Hu, Zongli [1 ]
Zhao, Zhiping [1 ]
Liang, Yan [1 ]
Li, Yong [1 ]
Chen, Guoping [1 ]
机构
[1] Chongqing Univ, Minist Educ, Bioengn Coll, Key Lab Biorheol Sci & Technol, Chongqing 400044, Peoples R China
基金
中国国家自然科学基金;
关键词
Thrombosis; Hirudin; 12-residue; Thrombin; NAP5; Platelet aggregation; Recombinant fusion protein; DEEP-VEIN THROMBOSIS; ANTICOAGULANT PEPTIDE; PULMONARY-EMBOLISM; HIRUDIN; THROMBOEMBOLISM; COAGULATION; HEPARIN;
D O I
10.2174/157018010790596605
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We designed a novel recombinant fusion protein r-NAP5-hirudin 12-residue- RGD with bi-functional inhibitory activities against platelet aggregation and thrombin. Our strategy may supply a potential multi-functional drug for the prevention and management of thrombosis.
引用
收藏
页码:182 / 187
页数:6
相关论文
共 50 条
  • [31] Novel fluorinated surfactants for perfluorochemical emulsification: Inhibitory effects on human platelet aggregation in vitro
    Edwards, CM
    Lowe, KC
    Heptinstall, S
    Trabelsi, H
    Lucas, P
    Cambon, A
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 : P264 - P264
  • [32] Role of the recombinant protein of the platelet receptor for type I collagen in the release of nitric oxide during platelet aggregation
    Chiang, TM
    Wang, YB
    Kang, ES
    THROMBOSIS RESEARCH, 2000, 100 (05) : 427 - 432
  • [33] MECHANISM OF INHIBITORY EFFECT OF SOME AMPHIPHILIC DRUGS ON PLATELET-AGGREGATION INDUCED BY COLLAGEN, THROMBIN OR ARACHIDONIC-ACID
    KANAHO, Y
    KOMETANI, M
    SATO, T
    FUJII, T
    THROMBOSIS RESEARCH, 1983, 31 (06) : 817 - 831
  • [34] A novel potent non-peptide mimetic based on the thrombin receptor S42FLLR46 sequence:: relaxation and platelet aggregation activities
    Androutsou, Maria-Eleni
    Alexopoulos, Kostas
    Roumelioti, Panagiota
    Papanastasiou, Ioannis
    Fatseas, Panagiotis
    Melissari, Euthemia
    Viahakos, Demetrios
    Mihailescu, Stefan
    Matsoukas, John
    PEPTIDES 2004, PROCEEDINGS: BRIDGES BETWEEN DISCIPLINES, 2005, : 609 - 610
  • [35] FUNCTIONAL-PROPERTIES OF A RECOMBINANT CHIMERIC PROTEIN WITH COMBINED THROMBIN INHIBITORY AND PLASMINOGEN-ACTIVATING POTENTIAL
    LIJNEN, HR
    WNENDT, S
    SCHNEIDER, J
    JANOCHA, E
    VANHOEF, B
    COLLEN, D
    STEFFENS, GJ
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 234 (01): : 350 - 357
  • [36] Inhibition of human and rabbit platelet aggregation by recombinant barbourin and barbourin-albumin fusion proteins and derivatives
    Marques, JA
    Sorensen, G
    George, J
    Sheffield, WP
    THROMBOSIS AND HAEMOSTASIS, 1999, : 249 - 249
  • [37] Inhibition of platelet aggregation: a novel effect of C-reactive protein
    Kreutz, R. P.
    Yoho, J.
    Bliden, K. P.
    Tantry, U. S.
    Gurbel, P. A.
    EUROPEAN HEART JOURNAL, 2008, 29 : 834 - 834
  • [38] Three New Phenylpropanoids from the Roots of Piper taiwanense and Their Inhibitory Activities on Platelet Aggregation and Mycobacterium tuberculosis
    Chen, Si
    Cheng, Ming-Jen
    Wu, Chin-Chung
    Peng, Chien-Fang
    Huang, Hung-Yi
    Chang, Hsun-Shuo
    Wang, Chyi-Jia
    Chen, Ih-Sheng
    CHEMISTRY & BIODIVERSITY, 2014, 11 (05) : 792 - 799
  • [39] A novel selective inhibitor to thrombin-induced platelet aggregation purified from the leech Whitmania pigra
    Liu, Xuan
    Wang, Caihui
    Ding, Xue
    Liu, Xiaodong
    Li, Qian
    Kong, Yi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 473 (01) : 349 - 354
  • [40] Glutathione S-transferase-rhodostomin fusion protein inhibits platelet aggregation and induces platelet shape change
    Chang, HH
    Tsai, WJ
    Lo, SCJ
    TOXICON, 1997, 35 (02) : 195 - 204